Skip to main content
Clinical Trials/NCT00991497
NCT00991497CompletedNot Applicable

A Randomised Controlled Trial to Compare the Outcome of Localised Varicosity Compression for 24 Hours and 5 Days After Foam Sclerotherapy to Truncal Varices

Gloucestershire Hospitals NHS Foundation Trust1 site in 1 country124 target enrollmentStarted: January 1, 2007Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
124
Locations
1
Primary Endpoint
Change in Aberdeen Varicose Vein Score from time of treatment to 2 and 6 weeks after treatment

Study Overview

Brief Summary

The purpose of this study is to compare the results of foam treatment of varicose veins (foam sclerotherapy) in patients who wear compression bandages for 24 hours or 5 days after treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Proven truncal venous incompetence (of >1 second duration) on venous duplex scanning. (Great saphenous vein (GSV), small saphenous vein (SSV), anterior accessory thigh vein (AATV) or other major tributary).
  • •Agreed preference for foam sclerotherapy treatment.
  • •Signed consent form agreeing to be part of the trial.

Exclusion Criteria

  • •Total deep venous reflux.
  • •Known allergy to liquid sclerosant.
  • •Pregnancy or breast feeding.
  • •Arterial disease.

Arms & Interventions

24 hours compression bandaging

Active Comparator

Intervention: Compression bandaging (Device)

5 days compression bandaging

Active Comparator

Intervention: Compression bandaging (Device)

Outcomes

Primary Outcomes

Change in Aberdeen Varicose Vein Score from time of treatment to 2 and 6 weeks after treatment

Time Frame: 2 and 6 weeks

Secondary Outcomes

  • Change in Burford pain score from time of treatment to 2 and 6 weeks after treatment(2 and 6 weeks)
  • Change in SF-36 score from time of treatment to 6 weeks after treatment.(6 weeks)
  • Target vein occlusion rate on duplex imaging at 6 weeks(6 weeks)
  • Number and type of complications seen(6 weeks)

Investigators

Study Sites (1)

Loading locations...

Similar Trials